Satisfaction with Long-Term Aesthetic and 10 Years Oncologic Outcome following Risk-Reducing Mastectomy and Implant-Based Breast Reconstruction with or without Nipple Preservation.
Loading...
Embargo End Date
ICR Authors
Authors
O'Connell, RL
Tasoulis, MK
Hristova, E
Teoh, V
Agusti, A
Ward, A
Montgomery, C
Mohammed, K
Self, J
Rusby, JE
Gui, G
Tasoulis, MK
Hristova, E
Teoh, V
Agusti, A
Ward, A
Montgomery, C
Mohammed, K
Self, J
Rusby, JE
Gui, G
Document Type
Journal Article
Date
2022-07-24
Date Accepted
Date Available
2022-07-28T10:16:45Z
Abstract
Incidence of bilateral risk-reducing mastectomies (RRMs) is increasing. The aim of this study was to compare satisfaction, aesthetic and oncological outcomes in women undergoing RRM with implant-based reconstruction comparing nipple-sparing mastectomy (NSM) with skin-sparing mastectomy (SSM) (sacrificing the nipple +/− nipple reconstruction). Women who had undergone bilateral RRM between 1997 and 2016 were invited. Aesthetic outcome and nipple symmetry were evaluated using standardized anthropometric measurements. The oncological outcome was assessed at last documented follow up. Ninety-three women (186 breasts) participated, 60 (64.5%) had NSM, 33 (35.5%) SSM. Median time between surgery and participation was 98.4 months (IQR: 61.7−133.9). Of the women, 23/33 (69.7%) who had SSM underwent nipple reconstruction. Nipple projection was shorter in the reconstructed SSM group than the maintained NSM group (p < 0.001). There was no significant difference in overall symmetry (p = 0.670), satisfaction regarding nipple preservation (p = 0.257) or overall nipple satisfaction (p = 0.074). There were no diagnoses of breast cancer at a median follow up of 129 months (IQR: 65−160.6). Women who undergo nipple-sparing RRM maintain long-term nipple symmetry. Nipple projection was less maintained after nipple reconstruction. Although satisfaction with the nipples was higher in the NSM group, this did not reach statistical significance. No breast cancers developed after RRM with long-term follow up.
Citation
Cancers, 2022, 14 (15), pp. 3607 - 3607
Rights
Source Title
Cancers
Publisher
MDPI
ISSN
eISSN
2072-6694
2072-6694
2072-6694